A great number of studies have shown that Ki67 was regarded as the marker that provides prognosis for BC patients who have undergone NAC [8–10], and it has been observed that Ki67 is a factor that can predict the response to NAC [7, 11, 12]. The gene discussed is MKI67; the disease is breast cancer.